Fundz

Abbott acquires Exact Sciences for USD 105 per share

PUBLIC · ABTOct 01, 2026

Acquiring Company

Abbott Stringham & Lynch

Acquired Company

Exact Sciences

Abbott ParkMadisonManufacturingBiotechnologyHealth CareMedicalMedical DeviceBiotechnologyHealth CareHealth Diagnostics

Description

Abbott completed the acquisition of Exact Sciences on March 23, 2026, making it a wholly owned subsidiary. Exact Sciences stock ceased trading on Nasdaq and converted to cash at USD 105.00 per share. This acquisition integrates Exact Sciences into Abbott's Cancer Diagnostics business. The move aims to enhance Abbott's offerings in both population screening and precision oncology.

Company Information

Company

Abbott Stringham & Lynch

Location

Abbott Park, Illinois, United States

About

Founded in 1977, ASL offers a wealth of experience in delivering high-quality services and specialties to its clients. The firm works with emerging- and middle-market privately held businesses to help them thrive in their markets. ASL also partners with high-net-worth individuals – owners, founders, and executives – to help them protect and grow their wealth. The firm identifies untapped opportunities, challenges, and solutions, enabling clients to make effective and timely decisions today that lead to a fuller and more secure tomorrow. Designed to facilitate quality decisions, ASL's services cover corporate tax planning and compliance, assurance and accounting, estate and gift tax planning, litigation support, succession planning and valuation. The firm's services are contextualized by its specialties in real estate, construction, technology, family wealth and individual tax, emerging businesses, manufacturing and distribution, nonprofit organizations, renewable energy, and recreation and entertainment. ASL is a member of Allinial Global, a strategic affiliation of independent CPA firms who collaborate with each other to provide industry-specific tax, audit, and advisory expertise to clients worldwide. Contact Information:Sarah Hauge, Marketing Manager shauge@aslcpa.com408-377-8700 ext. 211 SOURCE Abbott, Stringham & Lynch

Fundz sees it the moment Abbott Stringham & Lynch makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Aquil
Senior decision-maker at this company
••••••••@••••••••

See Aquil's verified email →

Yakub
Senior decision-maker at this company
••••••••@••••••••

See Yakub's verified email →

Alaa
Senior decision-maker at this company
••••••••@••••••••

See Alaa's verified email →

Vikas
Likely contact at this company
••••••••@••••••••

See Vikas's verified email →

David
Likely contact at this company
••••••••@••••••••

See David's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Abbott Stringham & Lynch's next move

Learn about Strategic plan

Frequently asked

Who acquired Exact Sciences?

Exact Sciences was acquired by Abbott Stringham & Lynch, based in Abbott Park. The deal was reported on October 1, 2026. Founded in 1977, ASL offers a wealth of experience in delivering high-quality services and specialties to its clients. Abbott Stringham & Lynch is publicly traded (ABT) and operates in Manufacturing.

When did Abbott Stringham & Lynch acquire Exact Sciences?

Abbott Stringham & Lynch's acquisition of Exact Sciences was reported on October 1, 2026. Abbott completed the acquisition of Exact Sciences on March 23, 2026, making it a wholly owned subsidiary. Exact Sciences stock ceased trading on Nasdaq and converted to cash at USD 105.00 per share. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Exact Sciences do?

Exact Sciences Corp. is a leading provider of cancer screening and diagnostic tests, known for its innovative solutions in early cancer detection. It is privately held, operating in Biotechnology, and is based in Madison.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.